Requip and Tequin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Requip (ropinirole hydrochloride) and Tequin (gatifloxacin). Common drug interactions include anaemia among females and gait disturbance among males.

The phase IV clinical study analyzes what interactions people have when they take Requip and Tequin. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Requip?

Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.

What is Tequin?

Tequin has active ingredients of gatifloxacin. eHealthMe is studying from 4,645 Tequin users. Check the latest studies of Tequin.

On Jul, 16, 2026

22 people who take Requip and Tequin together, and have interactions are studied.

What are the common drug interactions of Requip and Tequin, by gender? *:

female:

Anaemia (lack of blood)
Arthralgia (joint pain)
Back pain
Dysphonia (speech disorder attributable to a disorder of phonation)
Myalgia (muscle pain)
Pain in extremity
Bone disorder
Dental caries
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Facial pain

male:

Gait disturbance
Hypoaesthesia (reduced sense of touch or sensation)
Joint contracture (a permanent shortening of a muscle or joint)
Joint range of motion decreased (disease of joint movement)
Mobility decreased (ability to move is reduced)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Oedema (fluid collection in tissue)
Pain
Pain in extremity

What are the common drug interactions of Requip and Tequin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Communication disorder (speech and language disorder)
Cough
Depressed level of consciousness
Drug level below therapeutic
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
Dysphagia (a condition in which swallowing is difficult or painful)
Dysphonia (speech disorder attributable to a disorder of phonation)
Eye movement disorder
Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch)
Muscle rigidity (muscle stiffness)

50-59:

Hypoaesthesia (reduced sense of touch or sensation)
Joint contracture (a permanent shortening of a muscle or joint)
Joint range of motion decreased (disease of joint movement)
Mobility decreased (ability to move is reduced)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Oedema (fluid collection in tissue)
Oedema peripheral (superficial swelling)
Pain
Pain in extremity

60+:

Anxiety
Pain
Dental caries
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Facial pain
Groin pain
Injury
Intervertebral disc disorder (spinal disc disorder)
Leukopenia (less number of white blood cells in blood)
Lumbar vertebral fracture

What are the existing conditions these people have? *

Pain: 14 people, 63.64%
Muscle Spasms (muscle contraction): 14 people, 63.64%
Nuclear Magnetic Resonance Imaging Brain: 3 people, 13.64%

* Approximation only. Some reports may have incomplete information.

Do you take Requip and Tequin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously